Core Viewpoint - Fourier has officially launched its first full-size humanoid robot, Care-bot GR-3, which emphasizes emotional connection and interaction, targeting markets such as social companionship and healthcare assistance [2][12]. Group 1: Product Features - The GR-3 features a height of 165 cm and a weight of 71 kg, equipped with 55 degrees of freedom for more human-like movements [6]. - The design incorporates a warm color palette and soft materials, aiming to reduce mechanical feelings and enhance user comfort [10]. - The battery system allows for a seamless switch between two batteries, providing a single-use endurance of up to 3 hours [11]. Group 2: Market Applications - The primary markets for GR-3 include social companionship in public spaces and educational environments, as well as healthcare settings for patient assistance and monitoring [2][13]. - Fourier's experience in the rehabilitation sector, with over 10 years in the field and presence in over 3,000 hospitals, positions the GR-3 to enhance patient care from admission to recovery [12]. Group 3: Strategic Partnerships - Runyang Technology has invested in Fourier, contributing to the development of materials used in GR-3, indicating a strategic collaboration to enhance product offerings [13][14]. - The investment is expected to expand Runyang's application of foam materials and align with emerging industry needs, thereby improving its competitive edge [14].

两融数据显示，该股最新（8月5日）两融余额为1.88亿元，其中，融资余额为1.88亿元，近10日增加 1053.21万元，环比增长5.94%。 润阳科技股价创出历史新高，截至14:06，该股上涨6.29%，股价报56.24元，成交量278.46万股，成交金 额1.52亿元，换手率4.24%，该股最新A股总市值达56.24亿元，该股A股流通市值36.93亿元。 证券时报·数据宝统计显示，润阳科技所属的基础化工行业，目前整体涨幅为0.48%，行业内，目前股价 上涨的有256只，涨停的有新瀚新材、科创新源等5只。股价下跌的有151只，跌幅居前的有上纬新材、 *ST亚太、晶华新材等，跌幅分别为19.72%、5.04%、4.88%。 公司发布的一季报数据显示，一季度公司共实现营业收入9604.06万元，同比增长0.34%，实现净利润 495.05万元，同比下降63.00%，基本每股收益为0.0495元，加权平均净资产收益率0.42%。（数据宝） （文章来源：证券时报网） ...

分组1 - Luzhou Laojiao announced a cash dividend of 45.92 RMB per 10 shares for the fiscal year 2024, totaling approximately 6.759 billion RMB [1] - *ST Huike's control change may terminate as the parties involved have sent a notice to withdraw from the share transfer agreement [2] - Raise Technology plans to acquire 49% of Sichuan Maikelong Vacuum New Materials Co., Ltd. for 231 million RMB, making it a subsidiary [3] 分组2 - Baotai received clinical trial approval for its innovative drug BAT5906, targeting retinal conditions [4] - Huate Dain's subsidiary signed an exclusive distribution agreement for melatonin granules in mainland China, with the product expected to be approved by July 2025 [5] - Jinghe Integration is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] 分组3 - Huatian Technology intends to establish a new subsidiary for advanced packaging with a total investment of 2 billion RMB [7] - Wehua New Materials is in preliminary discussions to acquire controlling interest in Jiangsu Heyutai Chemical Co., Ltd. [8] - Zhongyou Engineering's subsidiary received a project award in Iraq worth approximately 18.032 billion RMB [9] 分组4 - Chipone expects to achieve a revenue of 584 million RMB in Q2 2025, a 49.90% increase quarter-on-quarter [10] - Chang'an Automobile reported a 14.34% year-on-year increase in July sales [10] - Cangge Mining's net profit increased by 38.8% year-on-year in the first half of the year [10]

润阳科技(300920.SZ)公告称，根据询价申购情况，初步确定的本次询价转让价格为40.00元/股，共有6 份有效报价，涵盖基金管理公司、证券公司、私募基金管理人等专业机构投资者，合计有效认购股份数 量为535.6万股，对应有效认购倍数为2.40倍。本次询价转让拟转让股份已获全额认购，初步确定受让方 为4名机构投资者，拟受让股份总数为223.3357万股。转让结果以中国证券登记结算有限责任公司深圳 分公司最终办理结果为准。本次询价转让不涉及公司控制权变更，不会影响公司治理结构和持续经营。 ...

浙江润阳新材料科技股份有限公司 证券代码：300920 证券简称：润阳科技 公告编号：2025-057 股东询价转让定价情况提示性公告 费晓锋保证向浙江润阳新材料科技股份有限公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性和完整性依法承担法律责 任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： （二）本次询价转让收到有效报价单共6份，涵盖基金管理公司、证券公司、私 募基金管理人等专业机构投资者。 参与本次询价转让报价的机构投资者合计有效认购股份数量为5,356,000股，对 应的有效认购倍数为2.40倍。 （三）本次询价转让拟转让股份已获全额认购，初步确定受让方为4名机构投资 者，拟受让股份总数为2,233,357股。 二、相关风险提示 （一）本次询价转让受让方及受让股数仅为初步结果，尚存在拟转让股份被司 法冻结、扣划等风险。询价转让的最终结果以中国证券登记结算有限责任公司深圳 分公司最终办理结果为准。 （二）本次询价转让不涉及公司控制权变更，不会影响公司治理结构和持续经 营。 特此公告。 1、根据2025年8月1日询价申购 ...

二、对外投资进展情况 截至本公告日，公司已与上海傅利叶智能科技有限公司（已整体变更为上 海傅利叶智能科技股份有限公司，以下简称"傅利叶"）及相关方签署完成《 关于上海傅利叶智能科技有限公司之E3轮增资协议》《关于上海傅利叶智能 科技有限公司之E3轮股东协议》，并已按照相关约定向傅利叶支付全部投资 款。签署的协议主要内容与公司于2025年6月27日在巨潮资讯网上披露的《关 于对外投资暨增资上海傅利叶智能科技有限公司的进展公告》之"三、本次协 议（待签署）的主要内容"一致。 证券代码：300920 证券简称：润阳科技 公告编号：2025-058 浙江润阳新材料科技股份有限公司 关于签署完成《增资协议》暨对外投资进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、对外投资概述 2025年5月26日，公司第四届董事会第十五次会议审议通过了《关于签订 <投资意向协议>的议案》。具体内容详见公司2025年5月27日在巨潮资讯网披 露的《关于拟签订<投资意向协议>的公告》（公告编号：2025-043）。 2025年6月26日，公司第四届董事会第十七次会议审议通过了 ...

Group 1 - The stock price of Runyang Technology experienced fluctuations on July 31, opening at 55.45 yuan, reaching a high of 55.50 yuan, a low of 53.80 yuan, and closing at 54.14 yuan, down 1.74% from the previous trading day [1] - The company reported a trading volume of 28,977 hands and a transaction amount of 158 million yuan on the same day [1] - Runyang Technology specializes in the research, production, and sales of plastic products, with applications in various fields including baby products [1] Group 2 - Runyang Technology was included in the list of specialized and innovative enterprises as a listed company in Zhejiang [1] - The company's Q1 2025 financial report indicated a revenue of 96.04 million yuan and a net profit of 4.95 million yuan [1] - A shareholder, Fei Xiaofeng, announced plans to reduce holdings by transferring 2.2334% of the total shares, amounting to 2.23 million shares, with a minimum transfer price set at 70% of the average stock price over the previous 20 trading days [1] Group 3 - On July 31, the net inflow of main funds was 18.0046 million yuan, accounting for 0.51% of the circulating market value [2]

Group 1 - Jiejia Weichuang expects a net profit of 1.7 billion to 1.96 billion yuan for the first half of 2025, representing a year-on-year increase of 38.65% to 59.85% [1] - Micron Biotech's CS231295 clinical trial application has been approved by the FDA for treating advanced solid tumors [1] - Sinopec anticipates a net profit of 20.1 billion to 21.6 billion yuan for the first half of 2025, a decrease of 39.5% to 43.7% year-on-year [2] Group 2 - High Energy Environment has obtained a loan commitment letter from a financial institution for share repurchase [2] - Electric Power Investment Energy received a warning letter from the Inner Mongolia Securities Regulatory Bureau for inadequate disclosure in its semi-annual report [3] - Zhejiang University Net New won a bid for an intelligent engineering project worth 94.2712 million yuan [5] Group 3 - Daodaoquan reported a net profit of 181 million yuan for the first half of 2025, a year-on-year increase of 563.15% [8] - New Light Optoelectronics expects a net loss of 19 million to 23 million yuan for the first half of 2025 [9] - Aihua Pharmaceutical's two probiotic powder registration applications have been accepted [10] Group 4 - Xinhui Electric's subsidiary signed a product sales framework contract for commercial and household robots [11] - Baida Precision Engineering's subsidiary obtained 134,500 square meters of industrial land use rights [12] - Haiyang Technology's chief engineer resigned for personal reasons [13] Group 5 - Tianhe Magnetic Materials received a project filing notice for a 12,000-ton magnetic material deep processing project [22] - Wanlima is the pre-selected unit for a procurement project worth 43.835 million yuan from China Southern Airlines [24] - Yipin Hong's subsidiaries obtained two drug registration certificates [25] Group 6 - Zhejiang Jiaoke's subsidiary signed new construction projects worth 4.783 billion yuan in the second quarter [27] - Shenglan Co. received approval for issuing convertible bonds [29] - Jimi Technology expects a net profit of 88.6622 million yuan for the first half of 2025, a year-on-year increase of 2062.33% [31] Group 7 - Dingtong Technology reported a net profit of 115 million yuan for the first half of 2025, a year-on-year increase of 134.06% [32] - Huaheng Biological is planning to list on the Hong Kong Stock Exchange [34] - Yuntian Lihui submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [36] Group 8 - Nanchip Technology expects a net profit of 108.8 million to 133.1 million yuan for the first half of 2025, a decrease of 35.09% to 47.03% year-on-year [43] - Anglikang's Mesobam injection has received a drug registration certificate [44] - Jida Zhengyuan's shareholder plans to reduce their stake by up to 0.998% [45]

润阳科技（300920）(300920.SZ)公告，公司持股7.2333%股东费晓锋拟询价转让223.34万股，占公司总 股本的比例为2.2334%。 ...

Group 1 - The core point of the article is that Fei Xiaofeng, a shareholder holding 7.2333% of Runyang Technology, intends to transfer 2.2334% of the company's total share capital, which amounts to 2,233,400 shares [1]